Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Optimized Expansion of the Implanted Transcatheter Aortic Valve to Reduce Hypoattenuating Leaflet Thickening in Non-atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Implantation: an International, Multicentre, Randomized Controlled Trial

NCT07042529 is registered in ClinicalTrials.gov with Ole De Backer as lead sponsor.

NCT NCT07042529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07042529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Optimized Expansion of the Implanted Transcatheter Aortic Valve to Reduce Hypoattenuating Leaflet Thickening in Non-atrial Fibrillation Patients Undergoing Transcatheter Aortic Valve Implantation: an International, Multicentre, Randomized Controlled Trial
Lead sponsor
Ole De Backer
Phase
Not applicable
Overall status
Recruiting
Start date
October 5, 2025
Completion date
July 1, 2033
Enrollment
1,010 (estimated)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

aortic stenosis disease, valvular heart disease